These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3935560)

  • 1. Metformin and the sulphonylureas: the comparative risk.
    Campbell IW
    Horm Metab Res Suppl; 1985; 15():105-11. PubMed ID: 3935560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of type 2 diabetes mellitus with special reference to metformin therapy.
    Campbell IW
    Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
    Vexiau P; Mavros P; Krishnarajah G; Lyu R; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study.
    van Dalem J; Brouwers MC; Stehouwer CD; Krings A; Leufkens HG; Driessen JH; de Vries F; Burden AM
    BMJ; 2016 Jul; 354():i3625. PubMed ID: 27413017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study.
    Gulliford M; Latinovic R
    Diabetes Metab Res Rev; 2004; 20(3):239-45. PubMed ID: 15133756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balancing risk and benefit with oral hypoglycemic drugs.
    Hamnvik OP; McMahon GT
    Mt Sinai J Med; 2009 Jun; 76(3):234-43. PubMed ID: 19421967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
    Berger W
    Horm Metab Res Suppl; 1985; 15():111-5. PubMed ID: 3865878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin-associated lactic acidosis: case reports and literature review.
    Chang CT; Chen YC; Fang JT; Huang CC
    J Nephrol; 2002; 15(4):398-402. PubMed ID: 12243370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative tolerability profiles of oral antidiabetic agents.
    Krentz AJ; Ferner RE; Bailey CJ
    Drug Saf; 1994 Oct; 11(4):223-41. PubMed ID: 7848543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biguanide related lactic acidosis: incidence and risk factors.
    Aguilar C; Reza A; García JE; Rull JA
    Arch Med Res; 1992; 23(1):19-24. PubMed ID: 1308787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study.
    Weir MA; Gomes T; Mamdani M; Juurlink DN; Hackam DG; Mahon JL; Jain AK; Garg AX
    Nephrol Dial Transplant; 2011 Jun; 26(6):1888-94. PubMed ID: 20974644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes.
    Holstein A; Egberts EH
    Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):405-14. PubMed ID: 14614647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
    Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin.
    Barnett AH; Dreyer M; Lange P; Serdarevic-Pehar M
    Diabetes Care; 2006 Aug; 29(8):1818-25. PubMed ID: 16873786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between adherence to oral anti-diabetic drugs and hypoglycaemia in persons with Type 2 diabetes.
    Quilliam BJ; Ozbay AB; Sill BE; Kogut SJ
    Diabet Med; 2013 Nov; 30(11):1305-13. PubMed ID: 23586474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metformin-associated lactic acidosis].
    Orban JC; Ghaddab A; Chatti O; Ichai C
    Ann Fr Anesth Reanim; 2006 Oct; 25(10):1046-52. PubMed ID: 17005358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study.
    Sadikot SM; Mogensen CE
    Diabetes Res Clin Pract; 2008 Dec; 82(3):391-5. PubMed ID: 18945509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin-associated lactic acidosis treated with continuous renal replacement therapy.
    Alivanis P; Giannikouris I; Paliuras C; Arvanitis A; Volanaki M; Zervos A
    Clin Ther; 2006 Mar; 28(3):396-400. PubMed ID: 16750454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.